We only have this paper's title and publication details.
Read it at the sourceThis correspondence addresses concerns regarding the follow-up approach in neurofibromatosis type 1 patients, suggesting benefit in reducing malignancy rates.
No takes yet. Share an insight, caveat, or question.
Iasella et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: